Stocks stay hot in Tuesday's premarket 🔥

U.S. large-caps are on pace to extend their winning streak today....                                                                                                                                                                                                                                                                                                                                                                                                                 December 19, 2023 | [Read Online]( Chris Dinello December 19, 2023 Good Morning! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. We’re back to our regularly scheduled programming today. The Closing Bell Roundup will be out at its usual time. Now, let's get ready to trade! Markets 📈 U.S. large-caps continued to perform well on Monday, but the small-cap Russell 2K took a small loss. - S&P 500 [+0.4%] - Dow [0.0%] - Nasdaq [+0.6%] - Russell 2K [-0.1%] S&P 500 futures are currently up by just shy of 0.2%, so we could be heading for a higher open. Sponsored [CRITICAL January 31st Warning]( Jason Bodner has an urgent new warning. He believes the most popular investment of 2023 is set to pop... And it could all start just days from now. This has NOTHING to do with A.I. stocks… It has NOTHING to do with crypto currency... And it has NOTHING to do with high-flying tech stocks. Instead, this corner of the market you likely have cash parked in has swelled to nearly $6 trillion. [Click here to watch this warning now.]( Premarket Highlights 🔎 💹 Yen Dips as Bank of Japan Holds Steady on Rates The Bank of Japan (BOJ) has chosen to stay the course in its latest meeting, keeping short-term interest rates at minus 0.1%. This decision, along with the absence of hints on near-term policy changes, led to a significant weakening of the yen. 📉 Yen's Reaction: Following the BOJ's announcement, the yen experienced a sharp drop, weakening by over 1% and trading as weak as 144.68 against the dollar. 📈 Market Responses: Japanese Government Bonds saw a rally post-announcement, and Japan's benchmark stock index, the Nikkei 225, climbed by 1.4% on the news. 🔍 Looking Ahead: - No Clues from Ueda: While many analysts anticipate an end to negative interest rates by the BOJ in the first half of next year, Governor Kazuo Ueda did not offer any specific insights. He expressed the need for more evidence of a positive cycle of rising wages and prices in Japan. - Communication Caution: Ueda emphasized the challenge of communicating rate increases or giving a short-term rate outlook, as it could potentially lead to market confusion. - Fed's Influence: Acknowledging that potential Federal Reserve rate cuts could impact foreign-exchange rates, Ueda stated it would be inappropriate for the BOJ to hasten policy changes simply to preempt the Fed. In summary, the Bank of Japan's decision to maintain its negative interest rate policy has immediate effects on the yen and the bond market, while leaving investors speculating about the future direction of Japanese monetary policy. What to Watch Today 👀 Will the Hot Streak Continue? The market has performed very well since Federal Reserve Chairman Jerome Powell told investors the central bank has penciled in three rate cuts for 2024, but how long can the market keep up this momentum? It could be the perfect set up for a late-year “Santa Clause” rally, but remember that trading volume can get thin around the holidays. Significant pullbacks aren’t uncommon around the Christmas holiday, but investor sentiment seems to be running fairly high. Featured Earnings 💲 - Accenture [ACN] ... AM - FactSet [FDS] ... AM - FedEx [FDX] ... PM - Worthington Enterprises [WOR] ... PM - Enerpac Tool Group [EPAC] ... PM - Steelcase [SCS] ... PM Economy 🏗 - Housing starts [Nov] ... 8:30a - Building permits [Nov] ... 8:30a Running Hot 🔥 Gainers - Yoshiharu Global [YOSH] >> +22.0% - Jin Medical Intl. [ZJYL] >> +23.7% - Movano [MOVE] >> +24.8% Decliners - Micromobility [MCOM] >> (46.7%) - Motus GI [MOTS] >> (44.1%) - ETAO Intl. [ETAO] >> (40.5%) Panbela Therapeutics [PBLA] - Last Close: $1.01 This tiny biotech is running hot after announcing a new FDA drug approval that will trigger a developmental milestone payment to the company. US WorldMeds received FDA approval for the use of eflornithine as a maintenance therapy for high-risk neuroblastoma patients. Eflornithine was developed by Panbela, but ,in July 2023, it was divested to USWM in a deal that included $9.5 million in potential milestone payments. The drug’s approval bodes well for the triggering of the developmental, commercial, and clinical milestones. PBLA is up 68.3% on 15.2 million shares traded in response to the news. My Take: PBLA rallied 120% on Monday, after this news initially broke, so this rally is beginning to look somewhat top heavy. However, share prices could find new support at the $1 mark. InfoBird [IFBD] - Last Close: $1.35 The China-based SaaS company has landed a new business cooperation to speed the development of new IT systems. In a late Monday press release, InfoBird said the contract is worth roughly US$1.8 million. InforBird didn’t reveal the name of the contracted party, but the press release said its principal business is a Gig Economy Platform. Shares of IFBD are up 48.3% on 5.2 million shares traded. My Take: IFBD is a tiny company, and a $1.8 million contract is a big deal for them. However, there’s a chance we’ll see a pullback at some point. Compugen [CGEN] - Last Close: $0.73 An upcoming AstraZenece [AZN] clinical trial is expected to trigger a $10 million milestone payment for Compugen upon dosing of the first patient. AstraZeneca’s rilvegostomig drug was developed using Compugen’s TIGIT component, and an upcoming Phase 3 trial in biliary tract cancer patients will officially trigger the payments. The milestone payments were put in place as part of a 2018 licensing deal between the companies. Compugen also announced an exclusive license deal with Gilead Sciences [GILD] for its COM503 preclinical IL-18 biology program. CGEN is up 172.6% on all the good news, with 17.2 million shares traded. My Take: CGEN hit a couple of dingers this morning, and it could be a good set up for a swing trade, given the stocks recent pullback. LogicMark [LGMK] - Last Close: $0.9191 On Monday, Analysts from Refinitiv/Verus upgraded this tiny healthcare tech stock to “hold” from “sell.” Specific details of the note couldn’t be accessed at the time of writing, but the upgrade seems to be giving the stock a boost today. LGMK is up 45.8% on more than 3.7 million shares traded in the premarket. My Take: LGMK is a VERY small-float stock, so there’s a great chance we’re witnessing some target price manipulation here, given the scope of this sudden move. That's it for today! Thanks for reading, and good luck out there! Best Regards, — Chris D. Elite Trade Club Join Elite Growth Stocks now for INSTANT-ACCESS to our highest-rated research report. [Get Instant Access Now]( Text ELITE to 47121 or [click here]( to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign up for SMS]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2023 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247 Orlando, Florida 32828, United States of America